Cargando…
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors
Autores principales: | Li, Zhe, Lin, Yuxi, Huang, Yi-You, Liu, Runduo, Zhan, Chang-Guo, Wang, Xin, Luo, Hai-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923362/ https://www.ncbi.nlm.nih.gov/pubmed/33568500 http://dx.doi.org/10.1073/pnas.2024937118 |
Ejemplares similares
-
Reply to Behnam and Klein: Potential role of the His-tag in C-terminal His-tagged SARS-CoV-2 main protease
por: Li, Zhe, et al.
Publicado: (2021) -
Reply to Wang and Zhou
por: Jandl, Katharina, et al.
Publicado: (2023) -
Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
por: Li, Zhe, et al.
Publicado: (2020) -
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate()
por: Kuo, Chih-Jung, et al.
Publicado: (2004) -
Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
por: Lin, Yuxi, et al.
Publicado: (2021)